The importance of podocyte adhesion for a healthy glomerulus

Frontiers in Endocrinology

Volumn 5, Issue OCT, 2014, Pages

  Lennon, Rachel ^a,b,c   Randles, Michael J ^a,b   Humphries, Martin J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adhesion and signaling molecules; Cell junction; Extracellular matrix; Nephrotic syndrome; Podocyte

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; BINDING AFFINITY; BONE MARROW DERIVED DENDRITIC CELL; CELL MATURATION; CELL MIGRATION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN PHOSPHORYLATION; REVIEW; WESTERN BLOTTING;

EID: 84926680826     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00160     Document Type: Review

References (202)

1. Samuel T, Hoy WE, Douglas-Denton R, Hughson MD, Bertram JF. Applicability of the glomerular size distribution coefficient in assessing human glomerular volume: the Weibel and Gomez method revisited. J Anat (2007) 210:578-82. doi:10.1111/j.1469-7580.2007.00715.x
2. Singh A, Satchell SC, Neal CR, McKenzie EA, Tooke JE, Mathieson PW. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol (2007) 18:2885-93. doi:10.1681/ASN.2007010119
3. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med (2003) 348:101-8. doi:10.1056/NEJMoa020549
4. Couser W. Recurrent glomerulonephritis in the renal allograft: an update of selected areas. Exp Clin Transplant (2005) 3:283-8.
5. Hynes RO. The extracellular matrix: not just pretty fibrils. Science (2009) 326:1216-9. doi:10.1126/science.1176009
6. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell (2002) 110:673-87. doi:10.1016/S0092-8674(02)00971-6
7. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med (2006) 354:1387-401. doi:10.1056/NEJMra052131
8. Miner JH, Sanes JR. Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J Cell Biol (1994) 127:879-91. doi:10.1083/jcb.127.3.879
9. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, et al. The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol (1997) 137:685-701. doi:10.1083/jcb.137.3.685
10. Yurchenco PD, Tsilibary EC, Charonis AS, Furthmayr H. Laminin polymerization in vitro. Evidence for a two-step assembly with domain specificity. J Biol Chem (1985) 260:7636-44.
11. Paulsson M. The role of Ca2+ binding in the self-aggregation of laminin-nidogen complexes. J Biol Chem (1988) 263:5425-30.
12. Smyth N, Vatansever HS, Murray P, Meyer M, Frie C, Paulsson M, et al. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol (1999) 144:151-60. doi:10.1083/jcb.144.1.151
13. Miner JH, Li C, Mudd JL, Go G, Sutherland AE. Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation. Development (2004) 131:2247-56. doi:10.1242/dev.01112
14. Schittny JC, Yurchenco PD. Terminal short arm domains of basement membrane laminin are critical for its self-assembly. J Cell Biol (1990) 110:825-32. doi:10.1083/jcb.110.3.825
15. Yurchenco PD, Cheng YS. Self-assembly and calcium-binding sites in laminin. A three-arm interaction model. J Biol Chem (1993) 268:17286-99.
16. Purvis A, Hohenester E. Laminin network formation studied by reconstitution of ternary nodes in solution. J Biol Chem (2012) 287:44270-7. doi:10.1074/jbc. M112.418426
17. Colognato-Pyke H, O'Rear JJ, Yamada Y, Carbonetto S, Cheng YS, Yurchenco PD. Mapping of network-forming, heparin-binding, and alpha 1 beta 1 integrin-recognition sites within the alpha-chain short arm of laminin-1. J Biol Chem (1995) 270:9398-406. doi:10.1074/jbc.270.16.9398
18. Colognato H, Maccarrick M, O'Rear JJ, Yurchenco PD. The laminin alpha2-chain short arm mediates cell adhesion through both the alpha1beta1 and alpha2beta1 integrins. J Biol Chem (1997) 272:29330-6. doi:10.1074/jbc.272.46.29330
19. Nielsen PK, Yamada Y. Identification of cell-binding sites on the laminin alpha 5 N-terminal domain by site-directed mutagenesis. J Biol Chem (2001) 276:10906-12. doi:10.1074/jbc. M008743200
20. Garbe JH, Gohring W, Mann K, Timpl R, Sasaki T. Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains. Biochem J (2002) 362:213-21. doi:10.1042/0264-6021:3620213
21. Nishiuchi R, Takagi J, Hayashi M, Ido H, Yagi Y, Sanzen N, et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol (2006) 25:189-97. doi:10.1016/j.matbio.2005.12.001
22. Pierson M, Cordier J, Hervouuet F, Rauber G. An unusual congenital and familial congenital malformative combination involving the eye and kidney. J Genet Hum (1963) 12:184-213.
23. Matejas V, Hinkes B, Alkandari F, Al-Gazali L, Annexstad E, Aytac MB, et al. Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum Mutat (2010) 31:992-1002. doi:10.1002/humu.21304
24. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet (1995) 10:400-6. doi:10.1038/ng0895-400
25. Jarad G, Cunningham J, Shaw AS, Miner JH. Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest (2006) 116:2272-9. doi:10.1172/JCI28414
26. Suh JH, Jarad G, Vandevoorde RG, Miner JH. Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome. Proc Natl Acad Sci U S A (2011) 108:15348-53. doi:10.1073/pnas.1108269108
27. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development (2004) 131:1619-28. doi:10.1242/dev.01037
28. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med (2003) 348:2543-56. doi:10.1056/NEJMra022296
29. Vanacore R, Ham AJ, Voehler M, Sanders CR, Conrads TP, Veenstra TD, et al. A sulfilimine bond identified in collagen IV. Science (2009) 325:1230-4. doi:10.1126/science.1176811
30. Bhave G, Cummings CF, Vanacore RM, Kumagai-Cresse C, Ero-Tolliver IA, Rafi M, et al. Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. Nat Chem Biol (2012) 8:784-90. doi:10.1038/nchembio.1038
31. McCall AS, Cummings CF, Bhave G, Vanacore R, Page-McCaw A, Hudson BG. Bromine is an essential trace element for assembly of collagen IV scaffolds in tissue development and architecture. Cell (2014) 157:1380-92. doi:10.1016/j.cell.2014.05.009
32. Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol (2004) 15:2514-27. doi:10.1097/01.ASN.0000141462.00630.76
33. Grodecki KM, Gains MJ, Baumal R, Osmond DH, Cotter B, Valli VE, et al. Treatment of X-linked hereditary nephritis in samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol (1997) 117:209-25. doi:10.1016/S0021-9975(97)80016-3
34. Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, et al. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int (2003) 63:438-46. doi:10.1046/j.1523-1755.2003.00779.x
35. Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tonshoff B, et al. Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2012) 81:494-501. doi:10.1038/ki.2011.407
36. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 10:3137-46.
37. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet (1999) 23:354-8. doi:10.1038/15537
38. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, et al. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol (1999) 147:1109-22. doi:10.1083/jcb.147.5.1109
39. Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie JP, et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell (1996) 85:525-35. doi:10.1016/S0092-8674(00)81253-2
40. Goldberg S, Harvey SJ, Cunningham J, Tryggvason K, Miner JH. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrol Dial Transplant (2009) 24:2044-51. doi:10.1093/ndt/gfn758
41. Bader BL, Smyth N, Nedbal S, Miosge N, Baranowsky A, Mokkapati S, et al. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol (2005) 25:6846-56. doi:10.1128/MCB.25.15.6846-6856.2005
42. Suleiman H, Zhang L, Roth R, Heuser JE, Miner JH, Shaw AS, et al. Nanoscale protein architecture of the kidney glomerular basement membrane. Elife (2013) 2:e01149. doi:10.7554/eLife.01149
43. Lennon R, Byron A, Humphries JD, Randles MJ, Carisey A, Murphy S, et al. Global analysis reveals the complexity of the human glomerular extracellular matrix. J Am Soc Nephrol (2014) 25(5):939-51. doi:10.1681/ASN.2013030233
44. Byron A, Randles MJ, Humphries JD, Mironov A, Hamidi H, Harris S, et al. Glomerular cell cross-talk influences composition and assembly of extracellular matrix. J Am Soc Nephrol (2014) 25(5):953-66. doi:10.1681/ASN.2013070795
45. Sachs N, Sonnenberg A. Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol (2013) 9:200-10. doi:10.1038/nrneph.2012.291
46. Askari JA, Buckley PA, Mould AP, Humphries MJ. Linking integrin conformation to function. J Cell Sci (2009) 122:165-70. doi:10.1242/jcs.018556
47. Byron A, Humphries JD, Craig SE, Knight D, Humphries MJ. Proteomic analysis of alpha4beta1 integrin adhesion complexes reveals alpha-subunit-dependent protein recruitment. Proteomics (2012) 12:2107-14. doi:10.1002/pmic.201100487
48. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci (2006) 119:3901-3. doi:10.1242/jcs.03098
49. Winograd-Katz SE, Fassler R, Geiger B, Legate KR. The integrin adhesome: from genes and proteins to human disease. Nat Rev Mol Cell Biol (2014) 15:273-88. doi:10.1038/nrm3769
50. Humphries JD, Byron A, Bass MD, Craig SE, Pinney JW, Knight D, et al. Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6. Sci Signal (2009) 2:ra51. doi:10.1126/scisignal.2000396
51. Kuo JC, Han X, Hsiao CT, Yates JR III, Waterman CM. Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for beta-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol (2011) 13:383-93. doi:10.1038/ncb2216
52. Schiller HB, Hermann MR, Polleux J, Vignaud T, Zanivan S, Friedel CC, et al. Beta1-and alphav-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments. Nat Cell Biol (2013) 15:625-36. doi:10.1038/ncb2747
53. Woods A, Couchman JR. Integrin modulation by lateral association. J Biol Chem (2000) 275:24233-6. doi:10.1074/jbc. R000001200
54. Morgan MR, Humphries MJ, Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol (2007) 8:957-69. doi:10.1038/nrm2289
55. Korhonen M, Ylanne J, Laitinen L, Virtanen I. The alpha 1-alpha 6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron. J Cell Biol (1990) 111:1245-54. doi:10.1083/jcb.111.3.1245
56. Baraldi A, Furci L, Zambruno G, Rubbiani E, Annessi G, Lusvarghi E. Very late activation-3 integrin is the dominant beta 1-integrin on the glomerular capillary wall: an immunofluorescence study in nephrotic syndrome. Nephron (1992) 62:382-8. doi:10.1159/000187085
57. Sterk LM, De Melker AA, Kramer D, Kuikman I, Chand A, Claessen N, et al. Glomerular extracellular matrix components and integrins. Cell Adhes Commun (1998) 5:177-92. doi:10.3109/15419069809040290
58. Has C, Sparta G, Kiritsi D, Weibel L, Moeller A, Vega-Warner V, et al. Integrin alpha3 mutations with kidney, lung, and skin disease. N Engl J Med (2012) 366:1508-14. doi:10.1056/NEJMoa1110813
59. Nicolaou N, Margadant C, Kevelam SH, Lilien MR, Oosterveld MJ, Kreft M, et al. Gain of glycosylation in integrin alpha3 causes lung disease and nephrotic syndrome. J Clin Invest (2012) 122:4375-87. doi:10.1172/JCI64100
60. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, et al. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development (1996) 122:3537-47.
61. Sachs N, Kreft M, Van Den Bergh Weerman MA, Beynon AJ, Peters TA, Weening JJ, et al. Kidney failure in mice lacking the tetraspanin CD151. J Cell Biol (2006) 175:33-9. doi:10.1083/jcb.200603073
62. Kanasaki K, Kanda Y, Palmsten K, Tanjore H, Lee SB, Lebleu VS, et al. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol (2008) 313:584-93. doi:10.1016/j.ydbio.2007.10.047
63. Pozzi A, Jarad G, Moeckel GW, Coffa S, Zhang X, Gewin L, et al. Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev Biol (2008) 316:288-301. doi:10.1016/j.ydbio.2008.01.022
64. Yauch RL, Berditchevski F, Harler MB, Reichner J, Hemler ME. Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol Biol Cell (1998) 9:2751-65. doi:10.1091/mbc.9.10.2751
65. Karamatic Crew V, Burton N, Kagan A, Green CA, Levene C, Flinter F, et al. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood (2004) 104:2217-23. doi:10.1182/blood-2004-04-1512
66. Baleato RM, Guthrie PL, Gubler MC, Ashman LK, Roselli S. Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane. Am J Pathol (2008) 173:927-37. doi:10.2353/ajpath.2008.071149
67. Sachs N, Claessen N, Aten J, Kreft M, Teske GJ, Koeman A, et al. Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Invest (2012) 122:348-58. doi:10.1172/JCI58878
68. Vidal F, Aberdam D, Miquel C, Christiano AM, Pulkkinen L, Uitto J, et al. Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 10:229-34. doi:10.1038/ng0695-229
69. Kambham N, Tanji N, Seigle RL, Markowitz GS, Pulkkinen L, Uitto J, et al. Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa. Am J Kidney Dis (2000) 36:190-6. doi:10.1053/ajkd.2000.8293
70. Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med (2008) 14:55-63. doi:10.1038/nm1696
71. Amann K, Haas CS, Schussler J, Daniel C, Hartner A, Schocklmann HO. Beneficial effects of integrin alphavbeta3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis. Nephrol Dial Transplant (2012) 27:1755-68. doi:10.1093/ndt/gfr603
72. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 17:952-60. doi:10.1038/nm.2411
73. Beauvais DM, Burbach BJ, Rapraeger AC. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol (2004) 167:171-81. doi:10.1083/jcb.200404171
74. Hozumi K, Suzuki N, Nielsen PK, Nomizu M, Yamada Y. Laminin alpha1 chain LG4 module promotes cell attachment through syndecans and cell spreading through integrin alpha2beta1. J Biol Chem (2006) 281:32929-40. doi:10.1074/jbc. M605708200
75. McQuade KJ, Beauvais DM, Burbach BJ, Rapraeger AC. Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. J Cell Sci (2006) 119:2445-56. doi:10.1242/jcs.02970
76. Ogawa T, Tsubota Y, Hashimoto J, Kariya Y, Miyazaki K. The short arm of laminin gamma2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta4 chain. Mol Biol Cell (2007) 18:1621-33. doi:10.1091/mbc. E06-09-0806
77. Morgan MR, Hamidi H, Bass MD, Warwood S, Ballestrem C, Humphries MJ. Syndecan-4 phosphorylation is a control point for integrin recycling. Dev Cell (2013) 24:472-85. doi:10.1016/j.devcel.2013.01.027
78. Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol (2009) 10:843-53. doi:10.1038/nrm2799
79. Ezratty EJ, Bertaux C, Marcantonio EE, Gundersen GG. Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells. J Cell Biol (2009) 187:733-47. doi:10.1083/jcb.200904054
80. Huttenlocher A, Horwitz AR. Integrins in cell migration. Cold Spring Harb Perspect Biol (2011) 3:a005074. doi:10.1101/cshperspect.a005074
81. Fears CY, Woods A. The role of syndecans in disease and wound healing. Matrix Biol (2006) 25:443-56. doi:10.1016/j.matbio.2006.07.003
82. Jakobsson L, Kreuger J, Holmborn K, Lundin L, Eriksson I, Kjellen L, et al. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell (2006) 10:625-34. doi:10.1016/j.devcel.2006.03.009
83. Chen S, Wassenhove-McCarthy D, Yamaguchi Y, Holzman L, Van Kuppevelt TH, Orr AW, et al. Podocytes require the engagement of cell surface heparan sulfate proteoglycans for adhesion to extracellular matrices. Kidney Int (2010) 78:1088-99. doi:10.1038/ki.2010.136
84. Chen S, Wassenhove-McCarthy DJ, Yamaguchi Y, Holzman LB, Van Kuppevelt TH, Jenniskens GJ, et al. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int (2008) 74:289-99. doi:10.1038/ki.2008.159
85. Jin J, Sison K, Li C, Tian R, Wnuk M, Sung HK, et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell (2012) 151:384-99. doi:10.1016/j.cell.2012.08.037
86. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol (1993) 122:809-23. doi:10.1083/jcb.122.4.809
87. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, Carbonetto S. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem (1993) 268:14972-80.
88. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P. Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem (1998) 46:449-57. doi:10.1177/002215549804600404
89. Raats CJ, Van Den Born J, Bakker MA, Oppers-Walgreen B, Pisa BJ, Dijkman HB, et al. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol (2000) 156:1749-65. doi:10.1016/S0002-9440(10)65046-8
90. Kojima K, Davidovits A, Poczewski H, Langer B, Uchida S, Nagy-Bojarski K, et al. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction. J Am Soc Nephrol (2004) 15:2079-89. doi:10.1097/01.ASN.0000133531.43177.21
91. Kojima K, Nosaka H, Kishimoto Y, Nishiyama Y, Fukuda S, Shimada M, et al. Defective glycosylation of alpha-dystroglycan contributes to podocyte flattening. Kidney Int (2011) 79:311-6. doi:10.1038/ki.2010.403
92. Jarad G, Pippin JW, Shankland SJ, Kreidberg JA, Miner JH. Dystroglycan does not contribute significantly to kidney development or function, in health or after injury. Am J Physiol Renal Physiol (2011) 300:F811-20. doi:10.1152/ajprenal.00725.2010
93. Goult BT, Zacharchenko T, Bate N, Tsang R, Hey F, Gingras AR, et al. RIAM and vinculin binding to talin are mutually exclusive and regulate adhesion assembly and turnover. J Biol Chem (2013) 288:8238-49. doi:10.1074/jbc. M112.438119
94. Critchley DR, Gingras AR. Talin at a glance. J Cell Sci (2008) 121:1345-7. doi:10.1242/jcs.018085
95. Tian X, Kim JJ, Monkley SM, Gotoh N, Nandez R, Soda K, et al. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance. J Clin Invest (2014) 124:1098-113. doi:10.1172/JCI69778
96. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C. Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol (2007) 179:1043-57. doi:10.1083/jcb.200703036
97. Eimer W, Niermann M, Eppe MA, Jockusch BM. Molecular shape of vinculin in aqueous solution. J Mol Biol (1993) 229:146-52. doi:10.1006/jmbi.1993.1014
98. Winkler J, Lunsdorf H, Jockusch BM. The ultrastructure of chicken gizzard vinculin as visualized by high-resolution electron microscopy. J Struct Biol (1996) 116:270-7. doi:10.1006/jsbi.1996.0042
99. Chen H, Cohen DM, Choudhury DM, Kioka N, Craig SW. Spatial distribution and functional significance of activated vinculin in living cells. J Cell Biol (2005) 169:459-70. doi:10.1083/jcb.200410100
100. Bakolitsa C, Cohen DM, Bankston LA, Bobkov AA, Cadwell GW, Jennings L, et al. Structural basis for vinculin activation at sites of cell adhesion. Nature (2004) 430:583-6. doi:10.1038/nature02610
101. Carisey A, Tsang R, Greiner AM, Nijenhuis N, Heath N, Nazgiewicz A, et al. Vinculin regulates the recruitment and release of core focal adhesion proteins in a force-dependent manner. Curr Biol (2013) 23:271-81. doi:10.1016/j.cub.2013.01.009
102. Zamir E, Geiger B. Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci (2001) 114:3583-90.
103. Ziegler WH, Liddington RC, Critchley DR. The structure and regulation of vinculin. Trends Cell Biol (2006) 16:453-60. doi:10.1016/j.tcb.2006.07.004
104. Brown MC, Perrotta JA, Turner CE. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J Cell Biol (1996) 135:1109-23. doi:10.1083/jcb.135.4.1109
105. Brown MC, Perrotta JA, Turner CE. Serine and threonine phosphorylation of the paxillin LIM domains regulates paxillin focal adhesion localization and cell adhesion to fibronectin. Mol Biol Cell (1998) 9:1803-16. doi:10.1091/mbc.9.7.1803
106. Wang P, Ballestrem C, Streuli CH. The C terminus of talin links integrins to cell cycle progression. J Cell Biol (2011) 195:499-513. doi:10.1083/jcb.201104128
107. Brown MC, Turner CE. Paxillin: adapting to change. Physiol Rev (2004) 84:1315-39. doi:10.1152/physrev.00002.2004
108. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A (1992) 89:5192-6. doi:10.1073/pnas.89.11.5192
109. Schaller MD. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci (2010) 123:1007-13. doi:10.1242/jcs.045112
110. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (1995) 377:539-44. doi:10.1038/377539a0
111. Ma H, Togawa A, Soda K, Zhang J, Lee S, Ma M, et al. Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J Am Soc Nephrol (2010) 21:1145-56. doi:10.1681/ASN.2009090991
112. Delimont D, Dufek BM, Meehan DT, Zallocchi M, Gratton MA, Phillips G, et al. Laminin alpha2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis. PLoS One (2014) 9:e99083. doi:10.1371/journal.pone.0099083
113. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature (1996) 379:91-6. doi:10.1038/379091a0
114. Zervas CG, Gregory SL, Brown NH. Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol (2001) 152:1007-18. doi:10.1083/jcb.152.5.1007
115. Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol (2002) 12:787-97. doi:10.1016/S0960-9822(02)00810-2
116. Wickstrom SA, Lange A, Montanez E, Fassler R. The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase! EMBO J (2010) 29:281-91. doi:10.1038/emboj.2009.376
117. Fukuda K, Knight JD, Piszczek G, Kothary R, Qin J. Biochemical, proteomic, structural, and thermodynamic characterizations of integrin-linked kinase (ILK): cross-validation of the pseudokinase. J Biol Chem (2011) 286:21886-95. doi:10.1074/jbc. M111.240093
118. Hannigan GE, McDonald PC, Walsh MP, Dedhar S. Integrin-linked kinase: not so "pseudo" after all. Oncogene (2011) 30:4375-85. doi:10.1038/onc.2011.177
119. Qin J, Wu C. ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling. Curr Opin Cell Biol (2012) 24:607-13. doi:10.1016/j.ceb.2012.06.003
120. Nikolopoulos SN, Turner CE. Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J Cell Biol (2000) 151:1435-48. doi:10.1083/jcb.151.7.1435
121. Yamaji S, Suzuki A, Sugiyama Y, Koide Y, Yoshida M, Kanamori H, et al. A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol (2001) 153:1251-64. doi:10.1083/jcb.153.6.1251
122. Tu Y, Li F, Goicoechea S, Wu C. The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol (1999) 19:2425-34.
123. Tu Y, Huang Y, Zhang Y, Hua Y, Wu C. A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol (2001) 153:585-98. doi:10.1083/jcb.153.3.585
124. Chiswell BP, Zhang R, Murphy JW, Boggon TJ, Calderwood DA. The structural basis of integrin-linked kinase-PINCH interactions. Proc Natl Acad Sci U S A (2008) 105:20677-82. doi:10.1073/pnas.0811415106
125. Tu Y, Wu S, Shi X, Chen K, Wu C. Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell (2003) 113:37-47. doi:10.1016/S0092-8674(03)00163-6
126. Larjava H, Plow EF, Wu C. Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep (2008) 9:1203-8. doi:10.1038/embor.2008.202
127. Qu H, Tu Y, Shi X, Larjava H, Saleem MA, Shattil SJ, et al. Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with phosphoinositides and integrins. J Cell Sci (2011) 124:879-91. doi:10.1242/jcs.076976
128. Sakai T, Li S, Docheva D, Grashoff C, Sakai K, Kostka G, et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev (2003) 17:926-40. doi:10.1101/gad.255603
129. Montanez E, Wickstrom SA, Altstatter J, Chu H, Fassler R. Alpha-parvin controls vascular mural cell recruitment to vessel wall by regulating RhoA/ROCK signalling. EMBO J (2009) 28:3132-44. doi:10.1038/emboj.2009.295
130. Li S, Bordoy R, Stanchi F, Moser M, Braun A, Kudlacek O, et al. PINCH1 regulates cell-matrix and cell-cell adhesions, cell polarity and cell survival during the peri-implantation stage. J Cell Sci (2005) 118:2913-21. doi:10.1242/jcs.02422
131. Lange A, Wickstrom SA, Jakobson M, Zent R, Sainio K, Fassler R. Integrin-linked kinase is an adaptor with essential functions during mouse development. Nature (2009) 461:1002-6. doi:10.1038/nature08468
132. Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C, Dedhar S, et al. Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol (2006) 17:2164-75. doi:10.1681/ASN.2006010033
133. El-Aouni C, Herbach N, Blattner SM, Henger A, Rastaldi MP, Jarad G, et al. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J Am Soc Nephrol (2006) 17:1334-44. doi:10.1681/ASN.2005090921
134. Guo L, Sanders PW, Woods A, Wu C. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol (2001) 159:1735-42. doi:10.1016/S0002-9440(10)63020-9
135. Kretzler M, Teixeira VP, Unschuld PG, Cohen CD, Wanke R, Edenhofer I, et al. Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J (2001) 15:1843-5.
136. Rodewald R, Karnovsky MJ. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol (1974) 60:423-33. doi:10.1083/jcb.60.2.423
137. Farquhar MG, Wissig SL, Palade GE. Glomerular permeability. I. Ferritin transfer across the normal glomerular capillary wall. J Exp Med (1961) 113:47-66. doi:10.1084/jem.113.1.47
138. Caulfield JP, Farquhar MG. The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier. J Cell Biol (1974) 63:883-903. doi:10.1083/jcb.63.3.883
139. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell (1998) 1:575-82. doi:10.1016/S1097-2765(00)80057-X
140. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H, et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A (1999) 96:7962-7. doi:10.1073/pnas.96.14.7962
141. Gagliardini E, Conti S, Benigni A, Remuzzi G, Remuzzi A. Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol (2010) 21:2081-9. doi:10.1681/ASN.2010020199
142. Caulfield JP, Reid JJ, Farquhar MG. Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. Lab Invest (1976) 34:43-59.
143. Reeves W, Caulfield JP, Farquhar MG. Differentiation of epithelial foot processes and filtration slits: sequential appearance of occluding junctions, epithelial polyanion, and slit membranes in developing glomeruli. Lab Invest (1978) 39:90-100.
144. Ciani L, Patel A, Allen ND, Ffrench-Constant C. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol (2003) 23:3575-82. doi:10.1128/MCB.23.10.3575-3582.2003
145. Reiser J, Kriz W, Kretzler M, Mundel P. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol (2000) 11:1-8.
146. Fukasawa H, Bornheimer S, Kudlicka K, Farquhar MG. Slit diaphragms contain tight junction proteins. J Am Soc Nephrol (2009) 20:1491-503. doi:10.1681/ASN.2008101117
147. Yaoita E, Yao J, Yoshida Y, Morioka T, Nameta M, Takata T, et al. Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol (2002) 161:1597-606. doi:10.1016/S0002-9440(10)64438-0
148. Helmstadter M, Hohne M, Huber TB. A brief overview on IRM function across evolution. J Neurogenet (2014). doi:10.3109/01677063.2014.918976
149. Weavers H, Prieto-Sanchez S, Grawe F, Garcia-Lopez A, Artero R, Wilsch-Brauninger M, et al. The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm. Nature (2009) 457:322-6. doi:10.1038/nature07526
150. Zhuang S, Shao H, Guo F, Trimble R, Pearce E, Abmayr SM. Sns and Kirre, the Drosophila orthologs of nephrin and Neph1, direct adhesion, fusion and formation of a slit diaphragm-like structure in insect nephrocytes. Development (2009) 136:2335-44. doi:10.1242/dev.031609
151. Costa MS, Machado MC, Vieceli FM, Amista L, Baroneza JE, Yan CY, et al. The Rst-Neph family of cell adhesion molecules in Gallus gallus. J Neurogenet (2014). doi:10.3109/01677063.2014.933220
152. Ozkan E, Chia PH, Wang RR, Goriatcheva N, Borek D, Otwinowski Z, et al. Extracellular architecture of the SYG-1/SYG-2 adhesion complex instructs synaptogenesis. Cell (2014) 156:482-94. doi:10.1016/j.cell.2014.01.004
153. Khoshnoodi J, Sigmundsson K, Ofverstedt LG, Skoglund U, Obrink B, Wartiovaara J, et al. Nephrin promotes cell-cell adhesion through homophilic interactions. Am J Pathol (2003) 163:2337-46. doi:10.1016/S0002-9440(10)63590-0
154. Philippe A, Nevo F, Esquivel EL, Reklaityte D, Gribouval O, Tete MJ, et al. Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome. J Am Soc Nephrol (2008) 19:1871-8. doi:10.1681/ASN.2008010059
155. Putaala H, Sainio K, Sariola H, Tryggvason K. Primary structure of mouse and rat nephrin cDNA and structure and expression of the mouse gene. J Am Soc Nephrol (2000) 11:991-1001.
156. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, Barrish JP, et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol (2001) 21:4829-36. doi:10.1128/MCB.21.14.4829-4836.2001
157. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 24:349-54. doi:10.1038/74166
158. Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, et al. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet (2003) 12:3397-405. doi:10.1093/hmg/ddg360
159. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science (1999) 286:312-5. doi:10.1126/science.286.5438.312
160. Akilesh S, Koziell A, Shaw AS. Basic science meets clinical medicine: identification of a CD2AP-deficient patient. Kidney Int (2007) 72:1181-3. doi:10.1038/sj.ki.5002575
161. Tossidou I, Kardinal C, Peters I, Kriz W, Shaw A, Dikic I, et al. CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes. J Biol Chem (2007) 282:7457-64. doi:10.1074/jbc. M608519200
162. Lehtonen S, Ryan JJ, Kudlicka K, Iino N, Zhou H, Farquhar MG. Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and alpha-actinin are components of the nephrin multiprotein complex. Proc Natl Acad Sci U S A (2005) 102:9814-9. doi:10.1073/pnas.0504166102
163. Zaidel-Bar R. Cadherin adhesome at a glance. J Cell Sci (2013) 126:373-8. doi:10.1242/jcs.111559
164. Grahammer F, Schell C, Huber TB. The podocyte slit diaphragm-from a thin grey line to a complex signalling hub. Nat Rev Nephrol (2013) 9:587-98. doi:10.1038/nrneph.2013.169
165. New LA, Martin CE, Jones N. Advances in slit diaphragm signaling. Curr Opin Nephrol Hypertens (2014) 23:420-30. doi:10.1097/01.mnh.0000447018.28852.b6
166. Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, Wary KK, et al. Fyn binds to and phosphorylates the kidney slit diaphragm component nephrin. J Biol Chem (2003) 278:20716-23. doi:10.1074/jbc. M301689200
167. Jones N, Blasutig IM, Eremina V, Ruston JM, Bladt F, Li H, et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature (2006) 440:818-23. doi:10.1038/nature04662
168. Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman LB. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest (2006) 116:1346-59. doi:10.1172/JCI27414
169. George B, Verma R, Soofi AA, Garg P, Zhang J, Park TJ, et al. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J Clin Invest (2012) 122:674-92. doi:10.1172/JCI60070
170. George B, Fan Q, Dlugos CP, Soofi AA, Zhang J, Verma R, et al. Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis. Kidney Int (2014) 85:1382-94. doi:10.1038/ki.2013.556
171. Garg P, Verma R, Nihalani D, Johnstone DB, Holzman LB. Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol Cell Biol (2007) 27:8698-712. doi:10.1128/MCB.00948-07
172. Bisson N, Ruston J, Jeansson M, Vanderlaan R, Hardy WR, Du J, et al. The adaptor protein Grb2 is not essential for the establishment of the glomerular filtration barrier. PLoS One (2012) 7:e50996. doi:10.1371/journal.pone.0050996
173. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol (2003) 23:4917-28. doi:10.1128/MCB.23.14.4917-4928.2003
174. Zhu J, Sun N, Aoudjit L, Li H, Kawachi H, Lemay S, et al. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int (2008) 73:556-66. doi:10.1038/sj.ki.5002691
175. Schell C, Baumhakl L, Salou S, Conzelmann AC, Meyer C, Helmstadter M, et al. N-wasp is required for stabilization of podocyte foot processes. J Am Soc Nephrol (2013) 24:713-21. doi:10.1681/ASN.2012080844
176. Fan X, Li Q, Pisarek-Horowitz A, Rasouly HM, Wang X, Bonegio RG, et al. Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure. Cell Rep (2012) 2:52-61. doi:10.1016/j.celrep.2012.06.002
177. Canaud G, Bienaime F, Viau A, Treins C, Baron W, Nguyen C, et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med (2013) 19:1288-96. doi:10.1038/nm.3313
178. Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, Lennon R, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab (2010) 12:329-40. doi:10.1016/j.cmet.2010.08.015
179. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 24:251-6. doi:10.1038/73456
180. Scott RP, Hawley SP, Ruston J, Du J, Brakebusch C, Jones N, et al. Podocyte-specific loss of Cdc42 leads to congenital nephropathy. J Am Soc Nephrol (2012) 23:1149-54. doi:10.1681/ASN.2011121206
181. Sun H, Schlondorff J, Higgs HN, Pollak MR. Inverted formin 2 regulates actin dynamics by antagonizing Rho/diaphanous-related formin signaling. J Am Soc Nephrol (2013) 24:917-29. doi:10.1681/ASN.2012080834
182. Yu H, Suleiman H, Kim AH, Miner JH, Dani A, Shaw AS, et al. Rac1 activation in podocytes induces rapid foot process effacement and proteinuria. Mol Cell Biol (2013) 33:4755-64. doi:10.1128/MCB.00730-13
183. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med (2008) 14:1370-6. doi:10.1038/nm.1879
184. Schaldecker T, Kim S, Tarabanis C, Tian D, Hakroush S, Castonguay P, et al. Inhibition of the TRPC5 ion channel protects the kidney filter. J Clin Invest (2013) 123:5298-309. doi:10.1172/JCI71165
185. Blattner SM, Hodgin JB, Nishio M, Wylie SA, Saha J, Soofi AA, et al. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury. Kidney Int (2013) 84:920-30. doi:10.1038/ki.2013.175
186. Huber TB, Hartleben B, Winkelmann K, Schneider L, Becker JU, Leitges M, et al. Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol (2009) 20:798-806. doi:10.1681/ASN.2008080871
187. Satoh D, Hirose T, Harita Y, Daimon C, Harada T, Kurihara H, et al. aPKClambda maintains the integrity of the glomerular slit diaphragm through trafficking of nephrin to the cell surface. J Biochem (2014) 156(2):115-28. doi:10.1093/jb/mvu022
188. Soda K, Balkin DM, Ferguson SM, Paradise S, Milosevic I, Giovedi S, et al. Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. J Clin Invest (2012) 122:4401-11. doi:10.1172/JCI65289
189. Arif E, Wagner MC, Johnstone DB, Wong HN, George B, Pruthi PA, et al. Motor protein Myo1c is a podocyte protein that facilitates the transport of slit diaphragm protein Neph1 to the podocyte membrane. Mol Cell Biol (2011) 31:2134-50. doi:10.1128/MCB.05051-11
190. Krendel M, Osterweil EK, Mooseker MS. Myosin 1E interacts with synaptojanin-1 and dynamin and is involved in endocytosis. FEBS Lett (2007) 581:644-50. doi:10.1016/j.febslet.2007.01.021
191. Krendel M, Kim SV, Willinger T, Wang T, Kashgarian M, Flavell RA, et al. Disruption of myosin 1e promotes podocyte injury. J Am Soc Nephrol (2009) 20:86-94. doi:10.1681/ASN.2007111172
192. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet (2005) 37:739-44. doi:10.1038/ng1592
193. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science (2005) 308:1801-4. doi:10.1126/science.1106215
194. Conway DE, Breckenridge MT, Hinde E, Gratton E, Chen CS, Schwartz MA. Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Curr Biol (2013) 23:1024-30. doi:10.1016/j.cub.2013.04.049
195. Mathieson PW. The podocyte as a target for therapies-new and old. Nat Rev Nephrol (2012) 8:52-6. doi:10.1038/nrneph.2011.171
196. Lin S, Li D, Jia J, Zheng Z, Jia Z, Shang W. Spironolactone ameliorates podocytic adhesive capacity via restoring integrin alpha 3 expression in streptozotocin-induced diabetic rats. J Renin Angiotensin Aldosterone Syst (2010) 11:149-57. doi:10.1177/1470320310369603
197. Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW. Direct effects of dexamethasone on human podocytes. Kidney Int (2006) 70:1038-45. doi:10.1038/sj.ki.5001655
198. Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, et al. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2013) 369:2416-23. doi:10.1056/NEJMoa1304572
199. Goodman SL, Picard M. Integrins as therapeutic targets. Trends Pharmacol Sci (2012) 33:405-12. doi:10.1016/j.tips.2012.04.002
200. Lin X, Suh JH, Go G, Miner JH. Feasibility of repairing glomerular basement membrane defects in Alport syndrome. J Am Soc Nephrol (2014) 25:687-92. doi:10.1681/ASN.2013070798
201. Liu XL, Done SC, Yan K, Kilpelainen P, Pikkarainen T, Tryggvason K. Defective trafficking of nephrin missense mutants rescued by a chemical chaperone. J Am Soc Nephrol (2004) 15:1731-8. doi:10.1097/01.ASN.0000129826.28932.FD
202. Arif E, Rathore YS, Kumari B, Ashish F, Wong HN, Holzman LB, et al. Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury. J Biol Chem (2014) 289:9502-18. doi:10.1074/jbc. M113.505743